Moscow Laboratory Group Gemotest Expands Cooperation with iSOFT

iSOFT Group LimitediSOFT Group Limited announces - The Gemotest group, one of the five biggest providers of laboratory diagnostic services in Moscow, expands its central laboratory network by integrating the iSOFT Laboratory Module for microbiology. After the successful implementation of the iSOFT laboratory information system in 2008 the diagnostics provider now wants to further expand its service profile in order to continue the set growth strategy in the future. The further development of the cooperation enables iSOFT to step forward into the Russian healthcare market and successfully widen its footprint in Eastern Europe.

Within this new project Gemotest will install the new iSOFT Laboratory microbiology module in the overarching network in its central laboratory in Moscow. In combination with the existing iSOFT Laboratory components the results of microbiological analysis will be integrated reliably into the workflow. This enables Gemotest to extend its services for special laboratory diagnostic examinations. Moreover, the high flexibility and scalability of the entire laboratory system allows for the implementation of additional 10 analytical devices into the IT environment of the laboratory group as well as the smooth set up of further working stations.

By this diversification Gemotest intends to increase its competitive position and win further market shares in the field of special laboratory diagnostic examinations. This aspect is an essential building block for the growth plans of the Russian diagnostics service provider.

"With Gemotest we found a partner in the Russian market, who already successfully implements modern IT systems for the management of workflow processes," said Peter Herrmann, Managing Director, iSOFT Health. "The Russian healthcare market with a total volume of approximately two billion U.S. Dollars and constant growth rates in the last few years is a key market for iSOFT. That's why it is particularly important to have strong regional partners and reference sites, who can serve as "Proof of Concept" for further potential customers."

The order allows Gemotest the implementation of a comprehensive laboratory infrastructure, which provides the necessary scalability to integrate additional devices and locations into the existing IT environment. To take advantage of this flexibility and scalability, Gemotest invested a total of approximately €100.000 in the expansion of the laboratory IT system as well as for support and system maintenance over five years.

Related news articles:

About Gemotest
The Moscow-based laboratory group Gemotest has entrusted more than 100 employees with the provision of diagnostic services. Every day up to 11,000 samples are analyzed and processed. The company, which for years pursued clear growth strategy, plans in the next years to establish other laboratory facilities in Russia and is one of the fastest-growing laboratory service providers in the country.

About iSOFT Group
iSOFT Group Limited (ASX: ISF) is the largest health information technology company listed on the Australian Securities Exchange, and among the world's biggest providers of advanced application solutions in modern healthcare economies.

iSOFT works with healthcare professionals to design and build software applications that answer all of the difficult questions posed by today's healthcare delivery challenges. Our solutions act as a catalyst for change, supporting free exchange of critical information across diverse care settings and participating organisations.

Today, more than 13,000 provider organisations in 40 countries use iSOFT's solutions to manage patient information and drive improvements in their core processes. The Group's sustainable development is delivered through careful planning, in-depth analysis of the market, and anticipation of our clients' evolving requirements. Our business is driven by the collective talent, experience and commitment of more than 4,700 specialists in 19 locations worldwide, including more than 2,700 technology and development professionals.

A global network of iSOFT subsidiaries, supported by an extensive partner network, provides substantial experience of national healthcare markets. As a result, we offer our clients comprehensive knowledge of local market requirements in terms of culture, language, working practices, regulation and organizational structure.

www.isofthealth.com

Most Popular Now

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

A Novel AI-Based Method Reveals How Cell…

Researchers from Tel Aviv University have developed an innovative method that can help to understand better how cells behave in changing biological environments, such as those found within a cancerous...